Falisa_Mustafa
☆    

Malaysia,
2011-02-10 10:23
(5616 d 02:29 ago)

Posting: # 6609
Views: 6,992
 

 highly variable drugs [Bioanalytics]

hi, good day!

i found it very difficult to search for literatures that have documented CV values of drugs that are considered as highly variable drugs, e.g simvastatin, itraconazole, lamivudine, etc.

i really appreciate if anyone can guide me to the references that will be able to help me in this subject, as i need to confirm whether certain active ingredients are highly variable or not.

TQ!!
Jaime_R
★★  

Barcelona,
2011-02-10 12:11
(5616 d 00:41 ago)

(edited on 2011-02-16 17:27)
@ Falisa_Mustafa
Posting: # 6610
Views: 6,185
 

 highly variable drugs

Hi Mustafa,

what is the rationale behind your question - because you have posted in the 'Bioanalytics'-category? Are you concerned about getting the calibration range range right?

❝ [...] CV values of drugs that are considered as highly variable drugs, e.g simvastatin, itraconazole, lamivudine, etc.


I'm afraid that any literature search for HVDs will give you quite incomplete results. You only can search for a particular drug and then try to get the CV (HVD >30%) from the studies' results. If the CV is not given, calculate it from the confidence interval & sample size - see one of Helmut's lectures (slides 10-16).

❝ [...] i need to confirm whether certain active ingredients are highly variable or not.


Don't mix up HVDs (Highly Variable Drugs) and HVDPs (Highly Variable Drug Products). HVDs show CV >30% if administered as a solution, i.e. the variability is caused by highly variable clearance. HVDPs are not necessarily HVDs also. See the results for diclofenac in one of Helmut's presentations: A solution shows a CV of only ~7%, effervescent tablets and IR ~12%, delayed release after a single dose ~22%, and dermal ~33%.

Regards, Jaime
drgunasakaran1
★★  
avatar

2011-02-13 16:29
(5612 d 20:23 ago)

@ Falisa_Mustafa
Posting: # 6623
Views: 6,106
 

 highly variable drugs

Dear Mr.Mustafa,

Check out the CHMP assessment report on Lamivudine which discuss about the intrasubject CV% in a bioequivalence study in the following link
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001111/WC500044180.pdf

Find the intrasubject CV% of Simvastatin and Itraconazole in the Public assessment report of Itraconazole and Simvastatin in the following links
http://www.lakemedelsverket.se/SPC_PIL/Pdf/par/Simvastatin%20Morningside,%20film-coated%20tablets.pdf
http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con046562.pdf

Regards,

Dr.S.Gunasakaran, MD

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
194 visitors (0 registered, 194 guests [including 19 identified bots]).
Forum time: 13:53 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5